Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Covid-19

Novartis and Sanofi to help make Pfizer-BioNTech COVID-19 vaccine

by Rick Mullin
February 6, 2021 | A version of this story appeared in Volume 99, Issue 5

 

Novartis and Sanofi have agreed to provide manufacturing services to Pfizer and BioNTech to get their messenger RNA (mRNA)-based COVID-19 vaccine out more quickly. Novartis will put the mRNA active into vials at its facility in Stein, Switzerland. Sanofi will provide similar dosage-making services in Frankfurt, Germany. Novartis says it is in talks with a number of drug companies about services including mRNA, therapeutic protein, and raw material production for COVID-19 vaccines and drugs.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.